Integration of Rare Diseases into Social Services
© Castro and Dan; licensee BioMed Central Ltd. 2014
Published: 11 November 2014
Social Services are instrumental to the empowerment of people living with rare diseases and to the improvement of their well-being and health. However, these services are still scarce and often not adapted to the needs of people living with rare diseases. Access to these services remains a challenge for patients and families affected by rare diseases.
The European Committee of Experts on Rare Diseases Joint Action Work Package 6 - “Specialised Social Services and Integration of RDs into social services and policies” (enabled by EC Co-funding 20112201) - aims at giving more visibility to existing Specialised Social Services and good practices as well as advocating for the integration of people living with rare diseases in services not specific/exclusive to rare diseases, by working on training of social services providers.
In order to achieve the objectives above, the following methods have been used: mapping of Specialised Social Services available in Europe via a collection of contacts among EURORDIS members and network; collecting guiding principles for Specialised Social Services and for the Training of social services providers through the organisation multi-stakeholder workshops; compiling case study documents on expert existing services by organising country visits to expert services and applying a detailed questionnaire; advocating for these services via policy fact sheets.
European Committee of Experts on Rare Diseases Join Action Work Package 6 has now made available a set of information on specialised social services and on consensual good practices essential to the improvement of holistic care of people living with rare diseases. As the leader of this Joint Action Work Package, EURORDIS encourages decision-makers, patient representatives, national authorities, patients and families to use these tools to move forward in integrating people living with rare diseases into social services, in coordination with the national plans and strategies for rare diseases.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.